Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard W K Hugenholtz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 9, 2003
Less medication switching after initial start with atypical antipsychoticsGerard W K Hugenholtz, Eibert R Heerdink, Willem A Nolen, et al.
European Journal of Clinical Pharmacology|March 14, 2003
Short-acting parenteral antipsychotics drive choice for classical versus atypical agentsGerard W K Hugenholtz, Joost J Stolker, Eibert R Heerdink, et al.
Bone|August 23, 2005
Risk of hip/femur fractures in patients using antipsychoticsGerard W K Hugenholtz, Eibert R Heerdink, Tjeerd P van Staa, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended dosesGerard W K Hugenholtz, Eibert R Heerdink, Joost J Stolker, et al.
Pharmacotherapy|January 7, 2014
Analysis of potential drug-drug interactions in medical intensive care unit patientsEsther V Uijtendaal, Lieke L M van Harssel, Gerard W K Hugenholtz, et al.
Clinical Pharmacokinetics|May 22, 2019
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid GlycoproteinWai Hong Man, Ingeborg Wilting, Eibert R Heerdink, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 9, 2003
Less medication switching after initial start with atypical antipsychoticsGerard W K Hugenholtz, Eibert R Heerdink, Willem A Nolen, et al.
European Journal of Clinical Pharmacology|March 14, 2003
Short-acting parenteral antipsychotics drive choice for classical versus atypical agentsGerard W K Hugenholtz, Joost J Stolker, Eibert R Heerdink, et al.
Bone|August 23, 2005
Risk of hip/femur fractures in patients using antipsychoticsGerard W K Hugenholtz, Eibert R Heerdink, Tjeerd P van Staa, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended dosesGerard W K Hugenholtz, Eibert R Heerdink, Joost J Stolker, et al.
Pharmacotherapy|January 7, 2014
Analysis of potential drug-drug interactions in medical intensive care unit patientsEsther V Uijtendaal, Lieke L M van Harssel, Gerard W K Hugenholtz, et al.
Clinical Pharmacokinetics|May 22, 2019
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid GlycoproteinWai Hong Man, Ingeborg Wilting, Eibert R Heerdink, et al.
Pageof 1